Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
European Archives of Oto-Rhino-Laryngology

05-04-2024 | Metastasis | Head and Neck

Patterns of failure in patients with nasopharyngeal cancer of Northeastern region of India: a retrospective observational study

Authors: Mouchumee Bhattacharyya, Partha Pratim Medhi, Prashasti Sharma, Jyotiman Nath, Apurba Kumar Kalita, Partha Sarathi Roy, Tashnin Rahman, Yanpothung Yanthan

Published in: European Archives of Oto-Rhino-Laryngology

Login to get access

Abstract

Purpose

We aimed to analyze patterns of failure and disease volume-treatment outcomes in patients with Nasopharyngeal carcinoma (NPC) treated with definitive radiation with or without concurrent chemotherapy at a tertiary cancer centre in northeast India.

Methods

From February 2018 to February 2022, 99 histopathologically proved non-metastatic NPC patients treated with curative-intent RT with or without chemotherapy were retrospectively analyzed. Locally advanced patients received neoadjuvant or adjuvant chemotherapy. The Cox proportional hazards model was used to investigate the impact of various prognostic factors on locoregional free survival (LRFS), distant metastasis free survival (DMFS), progression free survival (PFS) and overall survival (OS). The log-rank test and Kaplan–Meir curves compared outcome variables based on ROC analysis-classified tumor volume.

Results

During a median follow up of 25.4 months (17.3–39.2), 35(35.4%) patients developed recurrence. Twenty-three patients developed locoregional failures, of which 11 were in-field; 12 patient showed an out-field failure. The 3-year LRFS, DMFS, PFS and OS was 71.10%, 70.90%, 64.10% and 74.10% respectively. There was statistically significant difference in LRFS according to T staging (p < 0.0001). Gross tumor volume (GTVp) and gross nodal volume (GTVn) were an independent prognostic factor for OS, PFS, LRFS and DMFS. The cut-off volumes for GTVp and GTVn for distant metastases and locoregional failure, respectively, were found to be 13 and 22.7 mL and 3.7 and 39.2 mL, respectively, by ROC curve analysis. Based on this, 99 patients were divided into three subgroups. OS demonstrated significant differences among patients in different volume subgroups for GTVp (p = 0.03) and GTVn (p = 0.00024).

Conclusions

For NPC patients who undergo curative IMRT, primary tumour and nodal volumes are independent prognostic indicators. GTVp and GTVn are highly predictive of local control, distant metastases, disease-free survival, and overall survival. This justifies their use as quantitative prognostic indicator for NPC.
Appendix
Available only for authorised users
Literature
1.
Chang ET, Ye W, Zeng YX, Adami HO (2021) The evolving epidemiology of nasopharyngeal carcinoma. Cancer Epidemiol Biomark Prev 30(6):1035–1047CrossRef
2.
3.
Ho FCH, Tham IWK, Earnest A, Lee KM, Lu JJ (2012) Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta-analysis of clinical evidence. BMC Cancer 21(12):98CrossRef
4.
5.
Blanchard P, Lee A, Marguet S, Leclercq J, Ng WT, Ma J et al (2015) Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis. Lancet Oncol 16(6):645–655PubMedCrossRef
6.
Al-Sarraf M, LeBlanc M, Giri PG, Fu KK, Cooper J, Vuong T et al (1998) Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. J Clin Oncol 16(4):1310–1317PubMedCrossRef
7.
Lin S, Pan J, Han L, Zhang X, Liao X, Lu JJ (2009) Nasopharyngeal carcinoma treated with reduced-volume intensity-modulated radiation therapy: report on the 3-year outcome of a prospective series. Int J Radiat Oncol Biol Phys 75(4):1071–1078PubMedCrossRef
8.
Lee N, Xia P, Quivey JM, Sultanem K, Poon I, Akazawa C et al (2002) Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys 53(1):12–22PubMedCrossRef
9.
Kam MKM, Teo PML, Chau RMC, Cheung KY, Choi PHK, Kwan WH et al (2004) Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys 60(5):1440–1450PubMedCrossRef
10.
Wolden SL, Chen WC, Pfister DG, Kraus DH, Berry SL, Zelefsky MJ (2006) Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan–Kettering experience. Int J Radiat Oncol Biol Phys 64(1):57–62PubMedCrossRef
11.
Palazzi M, Orlandi E, Bossi P, Pignoli E, Potepan P, Guzzo M et al (2009) Further improvement in outcomes of nasopharyngeal carcinoma with optimized radiotherapy and induction plus concomitant chemotherapy: an update of the Milan experience. Int J Radiat Oncol Biol Phys 74(3):774–780PubMedCrossRef
12.
Tham IWK, Hee SW, Yeo RMC, Salleh PB, Lee J, Tan TWK et al (2009) Treatment of nasopharyngeal carcinoma using intensity-modulated radiotherapy-the national cancer centre singapore experience. Int J Radiat Oncol Biol Phys 75(5):1481–1486PubMedCrossRef
13.
Xiao WW, Huang SM, Han F, Wu SX, Lu LX, Lin CG et al (2011) Local control, survival, and late toxicities of locally advanced nasopharyngeal carcinoma treated by simultaneous modulated accelerated radiotherapy combined with cisplatin concurrent chemotherapy: long-term results of a phase 2 study. Cancer 117(9):1874–1883PubMedCrossRef
14.
15.
Teo P, Yu P, Lee WY, Leung SF, Kwan WH, Yu KH et al (1996) Significant prognosticators after primary radiotherapy in 903 nondisseminated nasopharyngeal carcinoma evaluated by computer tomography. Int J Radiat Oncol Biol Phys 36(2):291–304PubMedCrossRef
16.
Kwong DLW, Sham JST, Au GKH, Chua DTT, Kwong PWK, Cheng ACK et al (2004) Concurrent and adjuvant chemotherapy for nasopharyngeal carcinoma: a factorial study. J Clin Oncol 22(13):2643–2653PubMedCrossRef
17.
Liu MT, Hsieh CY, Chang TH, Lin JP, Huang CC, Wang AY (2003) Prognostic factors affecting the outcome of nasopharyngeal carcinoma. Jpn J Clin Oncol 33(10):501–508PubMedCrossRef
18.
19.
Wei WI, Sham JST (2005) Nasopharyngeal carcinoma. Lancet Lond Engl 365(9476):2041–2054CrossRef
20.
Wu Z, Su Y, Zeng RF, Gu MF, Huang SM (2014) Prognostic value of tumor volume for patients with nasopharyngeal carcinoma treated with concurrent chemotherapy and intensity-modulated radiotherapy. J Cancer Res Clin Oncol 140(1):69–76PubMedCrossRef
21.
Chang CC, Chen MK, Liu MT, Wu HK (2002) The effect of primary tumor volumes in advanced T-staged nasopharyngeal tumors. Head Neck 24(10):940–946PubMedCrossRef
22.
23.
Lee AW, Ng WT, Pan JJ, Poh SS, Ahn YC, AlHussain H et al (2018) International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiother Oncol 126(1):25–36PubMedCrossRef
24.
Grégoire V, Ang K, Budach W et al (2014) Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 110(1):172–181PubMedCrossRef
25.
Zheng W, Xu YJ, Qiu SF, Zong JF, Huang LL, Huang CB et al (2015) Analysis on clinical characteristics and influencing factors of patients with locoregionally advanced nasopharyngeal carcinoma. Asian Pac J Cancer Prev APJCP. 16(10):4393–4399PubMedCrossRef
26.
Chen S, Yang D, Liao X, Lu Y, Yu B, Xu M et al (2021) Failure patterns of recurrence and metastasis after intensity-modulated radiotherapy in patients with nasopharyngeal carcinoma: results of a multicentric clinical study. Front Oncol. 11:693199PubMedCrossRef
27.
Kong F, Ying H, Du C, Huang S, Zhou J, Chen J et al (2014) Patterns of local-regional failure after primary intensity modulated radiotherapy for nasopharyngeal carcinoma. Radiat Oncol Lond Engl. 9:60CrossRef
28.
Li JG, Venigalla P, Leeman JE, LaPlant Q, Setton J, Sherman E et al (2017) Patterns of nodal failure after intensity modulated radiotherapy for nasopharyngeal carcinoma. Laryngoscope 127(2):377–382PubMedCrossRef
29.
Xue F, Hu C, He X (2017) Long-term patterns of regional failure for nasopharyngeal carcinoma following intensity-modulated radiation therapy. J Cancer 8(6):993–999PubMedPubMedCentralCrossRef
30.
Maklad AM, Bayoumi Y, Senosy Hassan MA, Elawadi AA, AlHussain H, Elyamany A et al (2016) Patterns of failure and survival in patients with nasopharyngeal carcinoma treated with intensity-modulated radiation therapy in Saudi Arabia. OncoTargets Ther 25(9):6561–6567CrossRef
31.
Zeng L, Guo P, Li JG, Han F, Li Q, Lu Y et al (2015) Prognostic score models for survival of nasopharyngeal carcinoma patients treated with intensity-modulated radiotherapy and chemotherapy. Oncotarget 6(36):39373–39383PubMedPubMedCentralCrossRef
32.
Yi JL, Gao L, Huang XD, Li SY, Luo JW, Cai WM et al (2006) Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution. Int J Radiat Oncol Biol Phys. 65(1):161–168PubMedCrossRef
33.
Lee AWM, Sze WM, Au JSK, Leung SF, Leung TW, Chua DTT et al (2005) Treatment results for nasopharyngeal carcinoma in the modern era: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 61(4):1107–1116PubMedCrossRef
34.
Sun X, Su S, Chen C, Han F, Zhao C, Xiao W et al (2014) Long-term outcomes of intensity- modulated radiotherapy for 868 patients with nasopharyngeal carcinoma: an analysis of survival and treatment toxicities. Radiother Oncol. 110(3):398–403PubMedCrossRef
35.
Wong FCS, Ng AWY, Lee VHF, Lui CMM, Yuen KK, Sze WK et al (2010) Whole-field simultaneous integrated-boost intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 76(1):138–145PubMedCrossRef
36.
Teo P, Lee WY, Yu P (1996) The prognostic significance of parapharyngeal tumour involvement in nasopharyngeal carcinoma. Radiother Oncol 39(3):209–221PubMedCrossRef
37.
Yi W, Liu XM, Xia YF, Liu Q, Li JT (2010) Influence of level-Ib lymphadenopathy on the prognosis of nasopharyngeal carcinoma. Chin J Cancer 29(1):87–93PubMedCrossRef
38.
Tang LL, Liu LZ, Ma J, Zong JF, Huang Y, Lin AH et al (2006) The role of retropharyngeal lymph node metastasis in staging of nasopharyngeal carcinoma. Ai Zheng Aizheng Chin J Cancer 25(2):129–135
39.
40.
Qin L, Wu F, Lu H, Wei B, Li G, Wang R (2016) Tumor volume predicts survival rate of advanced nasopharyngeal carcinoma treated with concurrent chemoradiotherapy. Otolaryngol Head Neck Surg 155(4):598–605PubMedCrossRef
41.
42.
Chen C, Fei Z, Pan J, Bai P, Chen L (2011) Significance of primary tumor volume and T-stage on prognosis in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy. Jpn J Clin Oncol 41(4):537–542PubMedCrossRef
43.
Lee CC, Ho HC, Lee MS, Hsiao SH, Hwang JH, Hung SK et al (2008) Primary tumor volume of nasopharyngeal carcinoma: significance for survival. Auris Nasus Larynx 35(3):376–380PubMedCrossRef
44.
Chu ST, Wu PH, Hou YY, Chang KP, Chi CC, Lee CC (2008) Primary tumor volume of nasopharyngeal carcinoma: significance for recurrence and survival. J Chin Med Assoc JCMA 71(9):461–466PubMedCrossRef
45.
46.
Ni W, Qi W, Xu F, Cao W, Xu C, Chen J et al (2020) Prognostic value of nasopharynx tumour volume in local-regional advanced nasopharyngeal carcinoma. Ann Transl Med 8(5):223PubMedPubMedCentralCrossRef
47.
De Jaeger K, Merlo FM, Kavanagh MC, Fyles AW, Hedley D, Hill RP (1998) Heterogeneity of tumor oxygenation: relationship to tumor necrosis, tumor size, and metastasis. Int J Radiat Oncol Biol Phys 42(4):717–721PubMedCrossRef
48.
Evans SM, Koch CJ (2003) Prognostic significance of tumor oxygenation in humans. Cancer Lett 195(1):1–16PubMedCrossRef
49.
Johnson CR, Thames HD, Huang DT, Schmidt-Ullrich RK (1995) The tumor volume and clonogen number relationship: tumor control predictions based upon tumor volume estimates derived from computed tomography. Int J Radiat Oncol Biol Phys 33(2):281–287PubMedCrossRef
Metadata
Title
Patterns of failure in patients with nasopharyngeal cancer of Northeastern region of India: a retrospective observational study
Authors
Mouchumee Bhattacharyya
Partha Pratim Medhi
Prashasti Sharma
Jyotiman Nath
Apurba Kumar Kalita
Partha Sarathi Roy
Tashnin Rahman
Yanpothung Yanthan
Publication date
05-04-2024
Publisher
Springer Berlin Heidelberg
Keyword
Metastasis
Published in
European Archives of Oto-Rhino-Laryngology
Print ISSN: 0937-4477
Electronic ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-024-08624-x